Rachel M. Ndonye, Ph.D.

2006 University of Connecticut, Storrs, CT, United States 
Organic Chemistry
"Rachel Ndonye"
Mean distance: (not calculated yet)


Sign in to add mentor
Amy Ruth Howell grad student 2006 University of Connecticut
 (Synthesis of sphinganine-containing alpha-galactosylceramides.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Arora P, Venkataswamy MM, Baena A, et al. (2011) A rapid fluorescence-based assay for classification of iNKT cell activating glycolipids. Journal of the American Chemical Society. 133: 5198-201
Bricard G, Venkataswamy MM, Yu KO, et al. (2010) Α-galactosylceramide analogs with weak agonist activity for human iNKT cells define new candidate anti-inflammatory agents. Plos One. 5: e14374
Fox LM, Cox DG, Lockridge JL, et al. (2009) Recognition of lyso-phospholipids by human natural killer T lymphocytes. Plos Biology. 7: e1000228
Im JS, Arora P, Bricard G, et al. (2009) Kinetics and Cellular Site of Glycolipid Loading Control the Outcome of Natural Killer T Cell Activation Immunity. 30: 888-898
Vas J, Mattner J, Richardson S, et al. (2008) Regulatory roles for NKT cell ligands in environmentally induced autoimmunity. Journal of Immunology (Baltimore, Md. : 1950). 181: 6779-88
Wang X, Chen X, Rodenkirch L, et al. (2008) Natural killer T-cell autoreactivity leads to a specialized activation state. Blood. 112: 4128-38
Li Q, Ndonye RM, Illarionov PA, et al. (2007) Rapid identification of immunostimulatory alpha-galactosylceramides using synthetic combinatorial libraries. Journal of Combinatorial Chemistry. 9: 1084-93
Yu KO, Im JS, Illarionov PA, et al. (2007) Production and characterization of monoclonal antibodies against complexes of the NKT cell ligand alpha-galactosylceramide bound to mouse CD1d. Journal of Immunological Methods. 323: 11-23
Forestier C, Takaki T, Molano A, et al. (2007) Improved outcomes in NOD mice treated with a novel Th2 cytokine-biasing NKT cell activator. Journal of Immunology (Baltimore, Md. : 1950). 178: 1415-25
Matsuda JL, Zhang Q, Ndonye R, et al. (2006) T-bet concomitantly controls migration, survival, and effector functions during the development of Valpha14i NKT cells. Blood. 107: 2797-805
See more...